Last reviewed · How we verify
Drug Aripiprazole
At a glance
| Generic name | Drug Aripiprazole |
|---|---|
| Sponsor | Children's Hospital of Fudan University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine (PHASE4)
- Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole (PHASE4)
- Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR. (PHASE4)
- C-Cog in Early Course Schizophrenia Study (PHASE4)
- Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole (NA)
- Treating Negative Affect in Low Back Pain Patients (PHASE2, PHASE3)
- Trajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study
- Sequential Multiple Assignment Randomized Trial for Bipolar Depression (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Drug Aripiprazole CI brief — competitive landscape report
- Drug Aripiprazole updates RSS · CI watch RSS
- Children's Hospital of Fudan University portfolio CI